XM non fornisce servizi ai residenti degli Stati Uniti d'America.

China urges caution as price speculation grips herb and tea markets



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>China urges caution as price speculation grips herb and tea markets</title></head><body>

Investors push into tea and traditional Chinese medicine markets

Prices of some herbal plants have tripled in two years

Some tea brands have doubled in just a few months

Authorities warn against speculation, market manipulation

SHANGHAI/SINGAPORE, Aug 30 (Reuters) -With interest rates low and falling, stocks and property in the doldrums, speculators are pushing into obscure fringes of China's financial markets to find investment returns, sending herb and tea prices on a rollercoaster.

A flood of investment money has moved into tea and traditional Chinese medicine, prompting official warnings to the public not to get consumed by the fever of fast-rising prices and to speculators not to pump up markets.

Prices of some herbal plants have tripled over the past two years. Some brands of premium tea leaves, compressed and sold in the form of bricks, are selling for thousands of dollars having doubled in a matter of months.

The speculative frenzy comes at a time when the economy is struggling for growth as it grapples with deflationary pressures and weak consumer demand.

China's stock markets .CSI300, .SSEC are sluggish following three years of losses, while bond yields are near record lows, limiting returns for savers. New homes prices fell at their fastest pace in July in nine years, government data shows, extending a housing slump.

The weakness of China's traditional investment avenues has prompted speculators into murkier financial products in search of returns, two dealers in tea and medicinal plants said.

Speculative investments "have always been there. But they're more attractive in an economic downturn," said Liang Yuhuan, a tea dealer in southern city of Guangzhou.


IN HOT WATER

In the Chinese medicine market, the Kangmei Chinese Medicinal Material (China) total index hit a record high last month, up about 50% in three years.

Prices of certain herbal plants, such as Goldthread, white peony root and tree peony bark, have more than tripled in the past two years.

Tight supplies following floods were partly behind the rally, but a bigger factor was "manipulation by capital," said Xu Yucheng, a dealer in the eastern city of Bozhou, known as China's capital of traditional medicine.

The Bozhou Traditional Chinese Medicinal Material Association, an industry group, warned speculators in a statement last month not to "pump-up prices", prompting a modest correction. The Kangmei Index is down roughly 4% from its peak.

Also weighing on sentiment, China's State Administration for Market Regulation on Aug 9 published draft anti-monopoly guidelines for the pharmaceutical sector, including traditional Chinese medicine, raising the prospect of closer scrutiny of the market by authorities.

In the tea market, trading has been brisk in the premium Pu'er variety, which is considered by experts to improve in quality as it ages, and is traded and collected much like vintage wine.

Tea trading is more fragmented compared with the medicinal plant market. As some brands have rallied, others have fallen, tea dealers said.

Chinese state broadcaster CCTV reported in January that prices of Chang Shi Tea, a Pu'er brand from tea trading hub Guangzhou, shot up to 50,000 yuan ($7,023) per 2.5-kg brick, before plunging more than 80% overnight and burning investors.

Amid the gyrating prices, Fan Cha Holdings, which calls itself the Hermes of China's tea industry and has 500 shops across China, said this month in a statement on its official WeChat account that it had plunged into "grave crisis".

It did not explain publicly what had caused its crisis, but the announcement triggered a rush by people who had bought its products to ask for their money back.

Chairman Zheng Chaogen has suggested investors swap their tea or other claims for equity in the company, according to a company statement and video streaming via the official WeChat account. It also said it would sell assets and raise fresh capital.

Fan Cha did not respond to several requests for comment, including on what was behind the company's "grave crisis".

Several authorities have warned producers, without identifying any specifically, not to sell wealth management products.

The practice is rampant and involves "huge risks", the government of Liwan district, home to Guangzhou's wholesale tea market, said on July 25.

"Investors should be on high alert, and get rid of the whim to get rich overnight," it said.

One investor who bought Fan Cha teas said he initially made big profits, but after Fan Cha's statement he has had sleepless nights wondering if he will get his money back.

"The profit was so tempting that you couldn't resist it," said the investor, who declined to be identified because he said he felt ashamed by his actions.
($1=7.12 yuan)



Reporting by Samuel Shen in Shanghai and Tom Westbrook in Singapore; Editing by Neil Fullick

</body></html>

Disclaimer: le entità di XM Group forniscono servizi di sola esecuzione e accesso al nostro servizio di trading online, che permette all'individuo di visualizzare e/o utilizzare i contenuti disponibili sul sito o attraverso di esso; non ha il proposito di modificare o espandere le proprie funzioni, né le modifica o espande. L'accesso e l'utilizzo sono sempre soggetti a: (i) Termini e condizioni; (ii) Avvertenza sui rischi e (iii) Disclaimer completo. Tali contenuti sono perciò forniti a scopo puramente informativo. Nello specifico, ti preghiamo di considerare che i contenuti del nostro servizio di trading online non rappresentano un sollecito né un'offerta ad operare sui mercati finanziari. Il trading su qualsiasi mercato finanziario comporta un notevole livello di rischio per il tuo capitale.

Tutto il materiale pubblicato sul nostro servizio di trading online è unicamente a scopo educativo e informativo, e non contiene (e non dovrebbe essere considerato come contenente) consigli e raccomandazioni di carattere finanziario, di trading o fiscale, né informazioni riguardanti i nostri prezzi di trading, offerte o solleciti riguardanti transazioni che possano coinvolgere strumenti finanziari, oppure promozioni finanziarie da te non richieste.

Tutti i contenuti di terze parti, oltre ai contenuti offerti da XM, siano essi opinioni, news, ricerca, analisi, prezzi, altre informazioni o link a siti di terzi presenti su questo sito, sono forniti "così com'è", e vanno considerati come commenti generali sui mercati; per questo motivo, non possono essere visti come consigli di investimento. Dato che tutti i contenuti sono intesi come ricerche di investimento, devi considerare e accettare che non sono stati preparati né creati seguendo i requisiti normativi pensati per promuovere l'indipendenza delle ricerche di investimento; per questo motivo, questi contenuti devono essere considerati come comunicazioni di marketing in base alle leggi e normative vigenti. Assicurati di avere letto e compreso pienamente la nostra Notifica sulla ricerca di investimento non indipendente e la nostra Informativa sul rischio riguardante le informazioni sopra citate; tali documenti sono consultabili qui.

Avvertenza sul rischio: Il tuo capitale è a rischio. I prodotti con leva finanziaria possono non essere adatti a tutti. Ti chiediamo di consultare attentamente la nostra Informativa sul rischio.